Et(A) and et(B) receptor antagonists synergistically increase extracellular endothelin-1 levels in primary rat astrocyte cultures

Brain Research

Volumn 785, Issue 2, 1998, Pages 253-261

  Hasselblatt, Martin ^a   Kamrowski Kruck, Heike ^a   Jensen, Niels ^a   Schilling, Lothar ^b   Kratzin, Hartmut ^a   Sirén, Anna Leena ^a   Ehrenreich, Hannelore ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Astrocyte; Endothelin receptor antagonist; Endothelin 1; ET(A); ET(B); Hirudin; Rat; Thrombin

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); DARUSENTAN; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR ANTAGONIST; HIRUDIN; MESSENGER RNA; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; UNCLASSIFIED DRUG; CYCLO(TRP ASP PRO VAL LEU); CYCLO(TRP-ASP-PRO-VAL-LEU); CYCLOPEPTIDE; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; ENDOTHELIN RECEPTOR; HIRUDIN DERIVATIVE; OLIGOPEPTIDE; PHENYLPROPIONIC ACID DERIVATIVE; PIPERIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; THROMBIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; DRUG RECEPTOR BINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; ANIMAL; BINDING COMPETITION; BIOSYNTHESIS; BRAIN CORTEX; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; GENETIC TRANSCRIPTION; KINETICS; METABOLISM; SECRETION; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BINDING, COMPETITIVE; CELLS, CULTURED; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENDOTHELIN-1; ENDOTHELIN-3; HIRUDINS; KINETICS; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PHENYLPROPIONATES; PIPERIDINES; PYRIMIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; THROMBIN; TRANSCRIPTION, GENETIC;

EID: 0032472961     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01368-1     Document Type: Article

References (36)

1. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
2. Asano T., Ikegaki I., Suzuki Y., Satoh S., Shibuya M. Endothelin and the production of cerebral vasospasm in dogs. Biochem. Biophys. Res. Commun. 159:1989;1345-1351.
3. Barone F.C., Globus M.Y., Price W.J., White R.F., Storer B.L., Feuerstein G.Z., Busto R., Ohlstein E.H. Endothelin levels increase in rat focal and global ischemia. J. Cereb. Blood Flow Metab. 14:1994;337-342.
4. Clozel M., Breu V., Gray G.A., Kalina B., Löffler B.M., Burri K., Cassal J.M., Hirth G., Müller M., Neidhart W.et al. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270:1994;228-235.
5. Dihanich M., Kaser M., Reinhard E., Cunningham D., Monard D. Prothrombin mRNA is expressed by cells of the nervous system. Neuron. 6:1991;575-581.
6. Ehrenreich H., Anderson R.W., Ogino Y., Rieckmann P., Costa T., Wood G.P., Coligan J.E., Kehrl J.H., Fauci A.S. Selective autoregulation of endothelins in primary astrocyte cultures: endothelin receptor-mediated potentiation of endothelin-1 secretion. New Biol. 3:1991;135-141.
7. Ehrenreich H., Costa T., Clouse K.A., Pluta R.M., Ogino Y., Coligan J.E., Burd P.R. Thrombin is a regulator of astrocytic endothelin-1. Brain Res. 600:1993;201-207.
8. Ehrenreich H., Kehrl J.H., Anderson R.W., Rieckmann P., Vitkovic L., Coligan J.E., Fauci A.S. A vasoactive peptide, endothelin-3, is produced by and specifically binds to primary astrocytes. Brain Res. 538:1991;54-58.
9. Ehrenreich H., Lange M., Near K.A., Anneser F., Schoeller L.A., Schmid R., Winkler P.A., Kehrl J.H., Schmiedek P., Goebel F.D. Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res. Exp. Med. Berl. 192:1992;257-268.
10. Firth J.D., Ratcliffe P.J. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J. Clin. Invest. 90:1992;1023-1031.
11. Fujitani Y., Oda K., Takimoto M., Inui T., Okada T., Urade Y. Autocrine receptors for endothelins in the primary culture of endothelial cells of human umbilical vein. FEBS Lett. 298:1992;79-83.
12. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem. Biophys. Res. Commun. 199:1994;1461-1465.
13. Hama H., Sakurai T., Kasuya Y., Fujiki M., Masaki T., Goto K. Action of endothelin-1 on rat astrocytes through the ETB receptor. Biochem. Biophys. Res. Commun. 186:1992;355-362.
14. Ihara M., Noguchi K., Saeki T., Fukuroda T., Tsuchida S., Kimura S., Fukami T., Ishikawa K., Nishikibe M., Yano M. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci. 50:1992;247-255.
15. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc. Natl. Acad. Sci. USA. 86:1989;2863-2867.
16. Ishikawa K., Ihara M., Noguchi K., Mase T., Mino N., Saeki T., Fukuroda T., Fukami T., Ozaki S., Nagase T.et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA. 91:1994;4892-4896.
17. Karaki H., Sudjarwo S.A., Hori M. Novel antagonist of endothelin ETB1 and ETB2 receptors, BQ-788: effects on blood vessel and small intestine. Biochem. Biophys. Res. Commun. 205:1994;168-173.
18. Koseki C., Imai M., Hirata Y., Yanagisawa M., Masaki T. Autoradiographic distribution in rat tissues of binding sites for endothelin: a neuropeptide? Am. J. Physiol. 256:1989;R858-R866.
19. Koyama Y., Baba A. Endothelins are extracellular signals modulating cytoskeletal actin organization in rat cultured astrocytes. Neuroscience. 61:1994;1007-1016.
20. Levin E.R., Frank H.J., Pedram A. Endothelin receptors on cultured fetal rat diencephalic glia. J. Neurochem. 58:1992;659-666.
21. Löffler B.M., Breu V., Clozel M. Effect of different endothelin receptor antagonists and of the novel non-peptide antagonist Ro 46-2005 on endothelin levels in rat plasma. FEBS Lett. 333:1993;108-110.
22. MacCumber M.W., Ross C.A., Snyder S.H. Endothelin in brain: receptors, mitogenesis, and biosynthesis in glial cells. Proc. Natl. Acad. Sci. USA. 87:1990;2359-2363.
23. Ohlstein E.H., Nambi P., Douglas S.A., Edwards R.M., Gellai M., Lago A., Leber J.D., Cousins R.D., Gao A., Frazee J.S.et al. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc. Natl. Acad. Sci. USA. 91:1994;8052-8056.
24. Ozaki S., Ohwaki K., Ihara M., Fukuroda T., Ishikawa K., Yano M. ETB-mediated regulation of extracellular levels of endothelin-1 in cultured human endothelial cells. Biochem. Biophys. Res. Commun. 209:1995;483-489.
25. Patel T.R., McCulloch J. Failure of an endothelin antagonist to modify hypoperfusion after transient global ischaemia in the rat. J. Cereb. Blood Flow Metab. 16:1996;490-499.
26. Plumpton C., Ferro C.J., Haynes W.G., Webb D.J., Davenport A.P. The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br. J. Pharmacol. 119:1996;311-314.
27. Pollard K.M., Chan E.K.L., Grant B.J., Sullivan K.F., Tan E.M., Glass C.A. In vitro posttranslational modification of lamin B cloned from a human T-cell line. Mol. Cell. Biol. 10:1990;2164-2175.
28. Riechers H., Albrecht H.P., Amberg W., Baumann E., Bernard H., Bohm H.J., Klinge D., Kling A., Müller S., Raschack M., Unger L., Walker N., Wernet W. Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. J. Med. Chem. 39:1996;2123-2128.
29. Sakurai T., Yanagisawa M., Inoue A., Ryan U.S., Kimura S., Mitsui Y., Goto K., Masaki T. cDNA cloning, sequence analysis and tissue distribution of rat preproendothelin-1 mRNA. Biochem. Biophys. Res. Commun. 175:1991;44-47.
30. Sakurai T., Yanagisawa M., Takuwa Y., Miyazaki H., Kimura S., Goto K., Masaki T. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
31. J. Sambrook, E.F. Fritsch, T. Maniatis, Molecular Cloning - a Laboratory Manual, 2nd edn., Cold Spring Harbor Laboratory Press, New York, 1989, pp. 7.19-17.22.
32. Sensenbrenner M., Devilliers G., Bock E., Porte A. Biochemical and ultra-structural studies of cultured rat astroglial cells: effect of brain extract and dibutyryl cyclic AMP on glial fibrillary acidic protein and glial filaments. Differentiation. 17:1980;51-61.
33. Sokolovsky M., Galron R., Kloog Y., Bdolah A., Indig F.E., Blumberg S., Fleminger G. Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc. Natl. Acad. Sci. USA. 87:1990;4702-4706.
34. Spatz M., Stanimirovic D., Strasser A., McCarron R.M. Nitro-L-arginine augments the endothelin-1 content of cerebrospinal fluid induced by cerebral ischemia. Brain Res. 684:1995;99-102.
35. Supattapone S., Simpson A.W., Ashley C.C. Free calcium rise and mitogenesis in glial cells caused by endothelin. Biochem. Biophys. Res. Commun. 165:1989;1115-1122.
36. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.